Sort by
Refine Your Search
-
We invite applications from creative and motivated individuals to join Professor Sir Shankar Balasubramanian's group for a 4-year PhD studentship, working on a multidisciplinary project exploiting
-
Primary Supervisor -�Dr Gabrielle Davidson BACKGROUND� Wildlife gut microbiomes are critical for host biology and health, yet are highly variable and environmentally responsive, especially in birds. There�s now a pressing need to understand how these symbionts affect development and fitness....
-
PhD studentship: Defining the role of the pioneer factor FOXA1 in hormone-dependent cancer Supervisor: Professor Jason Carroll Course start date: 1st October 2026 Project details For further
-
This is a four-year (1+3 MRes/PhD) studentship funded through the Cambridge EPSRC Centre for Doctoral Training in Future Infrastructure and Built Environment: Unlocking Net Zero (FIBE3 CDT). Further
-
. Stipend: Full funding for 4 years covering a personal maintenance stipend starting at £21,500 per annum and the University Composition Fee. Fees: These positions are open to UK citizens or overseas students
-
- or tissue-microenvironment. Our existing collaborations with AstraZeneca have yielded very interesting data specific metabolites that are involved in the migration and positioning of regulatory (Tregs) and
-
chromatin profiling methods along with CRISPR/Cas9-meduated cell line engineering and various animal models. You will study the effects of the activation or depletion of chromatin-modifying enzymes using
-
of the genome. This position will be primarily based in the Balasubramanian Lab in the CRUK Cambridge Institute (CRUK CI), and will involve collaborative interactions with the group's sister lab in the Yusuf
-
Applications are invited for a fully funded 4-year PhD studentship based in the Department of Biochemistry, University of Cambridge, and the new AstraZeneca Discovery Centre in Cambridge
-
cancer, novel genetically engineered mouse models for the depletion of different CAF populations, in vitro three-dimensional pancreatic tumour organoid/fibroblast co-culture models, CRISPR-based